Malaria in pregnancy and the newborn

Advances in Experimental Medicine and Biology

Volumn 659, Issue , 2010, Pages 139-152

  Rogerson, Stephen J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; AZITHROMYCIN; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; GAMMA INTERFERON; INTERLEUKIN 1; MEFLOQUINE; PARASITE ANTIBODY; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; TUMOR NECROSIS FACTOR ALPHA;

AGE; ANEMIA; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CONGENITAL INFECTION; CONGENITAL MALARIA; DIZZINESS; DRUG SAFETY; FATIGUE; FEVER; GRAVITY; HEADACHE; HUMAN; INFECTION RISK; INFLAMMATION; LOW BIRTH WEIGHT; MALARIA; MALARIA FALCIPARUM; MATERNAL MORTALITY; MIXED INFECTION; MONOCYTE; NEWBORN; NONHUMAN; PARASITE PREVALENCE; PARASITE TRANSMISSION; PARASITEMIA; PLACENTA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; VERTICAL TRANSMISSION; DISEASE PREDISPOSITION; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM; PREGNANCY COMPLICATION; REVIEW;

AGE FACTORS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALARIA; MALE; PLASMODIUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

EID: 77950361904     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0981-7_12     Document Type: Article

References (71)

1. Bardaji, A., Sigauque, B., Bruni, L., Romagosa, C., Sanz, S., Mabunda, S., Mandomando, I., Aponte, J., Sevene, E., Alonso, P.L., & Menendez, C. (2008). Clinical malaria in African pregnant women. Malar J, (7), 27.
2. Barker, D.J. (2006). Adult consequences of fetal growth restriction. Clinical Obstetrics and Gynecology, (49), 270-283. (Pubitemid 44317915)
3. Beeson, J.G., Brown, G.V., Molyneux, M.E., Mhango, C., Dzinjalamala, F., & Rogerson, S.J. (1999). Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis, (180), 464-472. (Pubitemid 30256329)
4. Brabin, B.J. (1983). An analysis of malaria in pregnancy in Africa. Bull WHO, (61), 1005-1016. (Pubitemid 14181621)
5. Brabin, B.J., Agbaje, S.O., Ahmed, Y., & Briggs, N.D. (1999). A birthweight nomogram for Africa, as a malaria-control indicator. Ann Trop Med Parasitol, 93 (Suppl 1), S43-S57. (Pubitemid 30062188)
6. Brabin, B.J. & Rogerson, S.J. (2001). The epidemiology and outcomes of maternal malaria. In: P.E. Duffy, M. Fried (Eds.) Malaria in Pregnancy Deadly Parasite, Susceptible Host. pp. 27-52. London and New York: Taylor and Francis.
7. Brabin, L. (2004). The adolescent health gap in developing countries. Ann Trop Paediatr, (24), 115-116. (Pubitemid 38801765)
8. Clark, R.L., White, T.E., S, A.C., Gaunt, I., Winstanley, P., & Ward, S.A. (2004). Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol, (71), 380-394. (Pubitemid 40076263)
9. Coulibaly, S.O., Gies, S., & D'Alessandro, U. (2007). Malaria burden among pregnant women living in the rural district of Boromo, Burkina Faso. Am J Trop Med Hyg, (77), 56-60.
10. Desai, M., ter Kuile, F.O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R.D. (2007). Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis, (7), 93-104. (Pubitemid 46123132)
11. Dondorp, A., Nosten, F., Stepniewska, K., Day, N., &White, N. (2005). Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet, (366), 717-725. (Pubitemid 41207233)
12. Duffy, M.F., Byrne, T.J., Elliott, S.R., Wilson, D., Rogerson, S.J., Beeson, J.G., Noviyanti, R., & Brown, G.V. (2005). Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype. Mol Microbiol, (56), 774-788. (Pubitemid 40562369)
13. Duffy, M.F., Caragounis, A., Noviyanti, R., Kyriacou, H.M., Choong, E.K., Boysen, K., Healer, J., Rowe, J.A., Molyneux, M.E., Brown, G.V., & Rogerson, S.J. (2006a). Transcribed var genes associated with placental malaria in Malawian women. Infect Immun, 74(8), 4875-4883. (Pubitemid 44157275)
14. Duffy, M.F., Maier, A.G., Byrne, T.J., Marty, A.J., Elliott, S.R., O'Neill, M.T., Payne, P.D., Rogerson, S.J., Cowman, A.F., Crabb, B.S., & Brown, G.V. (2006b). VAR2SCA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol Biochem Parasitol, (148), 117-124. (Pubitemid 43946508)
15. Duffy, P.E. & Fried, M. (2003). Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun, (71), 6620-6623. (Pubitemid 37337723)
16. Fischer, P.R. (2003). Malaria and newborns. J Trop Pediatr, (49), 132-134. (Pubitemid 36789798)
17. Francis, S.E., Malkov, V.A., Oleinikov, A.V., Rossnagle, E., Wendler, J.P., Mutabingwa, T.K., Fried, M., & Duffy, P.E. (2007). Six genes are preferentially transcribed by the circulating and sequestered forms of Plasmodium falciparum parasites that infect pregnant women. Infect Immun, (75), 4838-4850. (Pubitemid 47502154)
18. Fried, M., Domingo, G.J., Gowda, C.D., Mutabingwa, T.K., & Duffy, P.E. (2006). Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. Exp Parasitol, 113(1), 36-42.
19. Fried, M. & Duffy, P.E. (1996). Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science, (272), 1502-1504. (Pubitemid 26200005)
20. Fried, M., Muga, R.O., Misore, A.O., & Duffy, P.E. (1998). Malaria elicits type 1 cytokines in the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes. J Immunol, (160), 2523-2530. (Pubitemid 28119939)
21. Garner, P., & Gulmezoglu, A.M. (2006). Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev, CD000169.
22. Genton, B., D'Acremont, V., Rare, L., Baea, K., Reeder, J.C., Alpers, M.P., & Mueller, I.M. (2008). Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med, (5), e127.
23. Green, M.D., van Eijk, A.M., van Ter Kuile, F.O., Ayisi, J.G., Parise, M.E., Kager, P.A., Nahlen, B.L., Steketee, R., & Nettey, H. (2007). Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis, (196), 1403-1408. (Pubitemid 351412014)
24. Guyatt, H.L. & Snow, R.W. (2001). The epidemiology and burden of Plasmodium falciparumrelated anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg, 64 (Suppl), 36-44. (Pubitemid 32552570)
25. Guyatt, H.L. & Snow, R.W. (2004). Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev, (17), 760-769, table of contents. (Pubitemid 39372515)
26. Haase, R.N., Megnekou, R., Lundquist, M., Ofori, M.F., Hviid, L., & Staalsoe, T. (2006). Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo. Infect Immun, (74), 3035-3038. (Pubitemid 43673018)
27. Hart, C.A. (1988). Pregnancy and host resistance. Baillieres Clin Immunol Allergy, (2), 735-757.
28. Hviid, L. (2004). The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective. Parasite Immunol, (26), 477-486. (Pubitemid 40461164)
29. Hviid, L. & Staalsoe, T. (2004). Malaria immunity in infants: a special case of a general phenomenon? Trends Parasitol, (20), 66-72. (Pubitemid 38121261)
30. Le Hesran, J.Y., Cot, M., Personne, P., Fievet, N., Dubois, B., Beyeme, M., Boudin, C., &, Deloron, P. (1997). Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol, (146), 826-831.
31. Lesko, C.R., Arguin, P.M., & Newman, R.D. (2007). Congenital malaria in the United States: a review of cases from 1966 to 2005. Arch Pediatr Adolesc Med, (161), 1062-1067. (Pubitemid 350074838)
32. Lindsay, S., Ansell, J., Selman, C., Cox, V., Hamilton, K., & Walraven, G. (2000). Effect of pregnancy on exposure to malaria mosquitoes. Lancet, (355), 1972. (Pubitemid 30326107)
33. Lucchi, N.W., Koopman, R., Peterson, D.S., & Moore, J.M. (2006). Plasmodium falciparuminfected red blood cells selected for binding to cultured syncytiotrophoblast bind to chondroitin sulfate A and induce tyrosine phosphorylation in the syncytiotrophoblast. Placenta, (27), 384-394.
34. Malhotra, I., Mungai, P., Muchiri, E., Kwiek, J.J., Meshnick, S.R., & King, C.L. (2006). Umbilical cord-blood infections with Plasmodium falciparum malaria are acquired antenatally in kenya. J Infect Dis, (194), 176-183. (Pubitemid 44087188)
35. Marsh, K. & Kinyanjui, S. (2006). Immune effector mechanisms in malaria. Parasite Immunol, (28), 51-60.
36. Maubert, B., Fievet, N., Tami, G., Cot, M., Boudin, C., & Deloron, P. (1999). Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women. Infect Immun, (67), 5367-5371. (Pubitemid 29455314)
37. Menendez, C. & Mayor, A. (2007). Congenital malaria: the least known consequence of malaria in pregnancy. Semin Fetal Neonatal Med, (12), 207-213. (Pubitemid 46680526)
38. Menendez, C., Ordi, J., Ismail, M.R., Ventura, P.J., Aponte, J.J., Kahigwa, E., Font, F., & Alonso, P.L. (2000). The impact of placental malaria on gestational age and birth weight. J Infect Dis, (181), 1740-1745. (Pubitemid 30387768)
39. Moormann, A.M., Sullivan, A.D., Rochford, R.A., Chensue, S.W., Bock, P.J., Nyirenda, T., & Meshnick, S.R. (1999). Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis, (180), 1987-1993.
40. Mutabingwa, T.K., Bolla, M.C., Li, J.L., Domingo, G.J., Li, X., Fried, M., & Duffy, P.E. (2005). Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med, (2), e407.
41. Nosten, F., McGready, R., Simpson, J.A., Thwai, K.L., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N.J. (1999). Effects of Plasmodium vivax malaria in pregnancy. Lancet, (354), 546-549. (Pubitemid 29381368)
42. Parise, M.E., Ayisi, J.G., Nahlen, B.L., Schultz, L.J., Roberts, J.M., Misore, A., Muga, R., Oloo, A.J., & Steketee, R.W. (1998). Efficacy of sufadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg, (59), 813-822.
43. Phillips-Howard, P.A. & Wood, D. (1996). The safety of antimalarial drugs in pregnancy. Drug Saf, (14), 131-145. (Pubitemid 26086050)
44. Poespoprodjo, J.R., Fobia, W., Kenangalem, E., Lampah, D.A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey, N.M., & Price, R.N. (2008). Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis, (46), 1374-1381. (Pubitemid 351589936)
45. Riley, E.M., Wagner, G.E., Akanmori, B.D., & Koram, K.A. (2001). Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol, (23), 51-59.
46. Rogerson, S.J., Brown, H.C., Pollina, E., Abrams, E.T., Tadesse, E., Lema, V.M., & Molyneux, M.E. (2003a). Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infect Immun, (71), 267-270. (Pubitemid 36026029)
47. Rogerson, S.J., Chaiyaroj, S.C., Ng, K., Reeder, J.C., & Brown, G.V. (1995). Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med, (182), 15-20.
48. Rogerson, S.J., Chaluluka, E., Kanjala, M., Mkundika, P., Mhango, C.G., & Molyneux, M.E. (2000). Intermittent sulphadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi 1997-1999. Trans R Soc Trop Med Hyg, (94), 549-553.
49. Rogerson, S.J., Hviid, L., Duffy, P.E., Leke, R.F., & Taylor, D.W. (2007). Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis, (7), 105-117. (Pubitemid 46123133)
50. Rogerson, S.J. & Menendez, C. (2006). Treatment and prevention of malaria in pregnancy: opportunities and challenges. Expert Rev Anti Infect Ther, (4), 687-702. (Pubitemid 44523945)
51. Rogerson, S.J., Pollina, E., Getachew, A., Tadesse, E., Lema, V.M., & Molyneux, M.E. (2003b). Placental monocyte infiltrates in response to Plasmodium falciparum infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg, (68), 115-119. (Pubitemid 38234859)
52. Salanti, A., Dahlback, M., Turner, L., Nielsen, M.A., Barfod, L., Magistrado, P., Jensen, A.T., Lavstsen, T., Ofori, M.F., Marsh, K., Hviid, L., & Theander, T.G. (2004). Evidence for the Involvement of VAR2SCA in pregnancy-associated Malaria. J Exp Med, (200), 1197-1203. (Pubitemid 39507059)
53. Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A.T., Sowa, M.P., Arnot, D.E., Hviid, L., & Theander, T.G. (2003). Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol, (49), 179-191. (Pubitemid 36792013)
54. Saute, F., Menendez, C., Mayor, A., Aponte, J., Gomez-Olive, X., Dgedge, M., & Alonso, P. (2002). Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections. Trop Med Int Health, (7), 19-28. (Pubitemid 34131807)
55. Singh, B., Kim Sung, L., Matusop, A., Radhakrishnan, A., Shamsul, S.S., Cox-Singh, J., Thomas, A.,&Conway, D.J. (2004). A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet, (363), 1017-1024. (Pubitemid 38410774)
56. Singh, N., Shukla, M.M., & Sharma, V.P. (1999). Epidemiology of malaria in pregnancy in central India. Bull WHO, (77), 567-572. (Pubitemid 29352537)
57. Snow, R.W., Guerra, C.A., Noor, A.M., Myint, H.Y., & Hay, S.I. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature, (434), 214-217. (Pubitemid 40388051)
58. Staalsoe, T., Shulman, C.E., Bulmer, J.N., Kawuondo, K., Marsh, K., & Hviid, L. (2004). Variant surface antigen-specific IgG and protection against clinical consequences of pregnancyassociated Plasmodium falciparum malaria. Lancet, (363), 283-289. (Pubitemid 38142411)
59. Steketee, R.W., Nahlen, B.L., Parise, M.E., & Menendez, C. (2001). The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg, (64), 28-35. (Pubitemid 32552569)
60. Suguitan, A.L., Jr., Leke, R.G., Fouda, G., Zhou, A., Thuita, L., Metenou, S., Fogako, J., Megnekou, R., & Taylor, D.W. (2003). Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J Infect Dis, (188), 1074-1082. (Pubitemid 37268260)
61. Tagbor, H., Bruce, J., Browne, E., Greenwood, B., & Chandramohan, D. (2008). Malaria in pregnancy in an area of stable and intense transmission: is it asymptomatic? Trop Med Int Health, 13(8), 1016-1021.
62. ter Kuile, F.O., van Eijk, A.M., & Filler, S.J. (2007). Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. Jama, (297), 2603-2616. (Pubitemid 46961032)
63. Tjitra, E., Anstey, N.M., Sugiarto, P.,Warikar, N., Kenangalem, E., Karyana,M., Lampah, D.A., & Price, R.N. (2008). Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Med, (5), e128.
64. Tobian, A.A.R., Mehlotra, R.K., Malhotra, I., Wamachi, A., Mungai, P., Koech, D., Ouma, J., Zimmerman, P., & King, C.L. (2000). Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae and P. ovale in Kenya. J Infect Dis, (182), 558-563. (Pubitemid 30651054)
65. Tuikue Ndam, N., Bischoff, E., Proux, C., Lavstsen, T., Salanti, A., Guitard, J., Nielsen, M.A., Coppee, J.Y., Gaye, A., Theander, T., David, P.H., & Deloron, P. (2008). Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression. PLoS ONE, (3), e1855.
66. Tuikue Ndam, N.G., Salanti, A., Bertin, G., Dahlback, M., Fievet, N., Turner, L., Gaye, A., Theander, T., & Deloron, P. (2005). High level of var2sca transcription by Plasmodium falciparum isolated from the placenta. J Infect Dis, (192), 331-335. (Pubitemid 40993404)
67. Viebig, N.K., Gamain, B., Scheidig, C., Lepolard, C., Przyborski, J., Lanzer, M., Gysin, J., &, Scherf, A. (2005). A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep, (6), 775-781. (Pubitemid 43108701)
68. Vleugels, M.P.H., Brabin, B., Eling, W.M.C., & de Graaf, R. (1989). Cortisol and Plasmodium falciparum infection in pregnant women in Kenya. Trans R Soc Trop Med Hyg, (83), 173-177. (Pubitemid 19265556)
69. Walter, P.R., Garin, Y., & Blot, P. (1982). Placental pathologic changes in malaria. A histologic and ultrastructural study. Am J Pathol, (109), 330-342. (Pubitemid 13167935)
70. Ward, S.A., Sevene, E.J., Hastings, I.M., Nosten, F., & McGready, R. (2007). Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis, (7), 136-144. (Pubitemid 46123134)
71. Yosaatmadja, F., Andrews, K.T., Duffy, M.F., Brown, G.V., Beeson, J.G., & Rogerson, S.J. (2008). Characterization of VAR2SCA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line. Malar J, (7), 51.